Pulmonary langerhans cell histiocytosis secondary to Marijuana use: a case report and systematic review of the literature

被引:0
作者
Zahid, Ibrahim [1 ]
Sohail, Aruba [2 ]
Tahir, Roohan [2 ]
Belardo, Matthew [3 ]
Hooks, Brandon [4 ]
机构
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA
[2] DUHS, Dow Med Coll, Karachi, Pakistan
[3] Franciscan Hlth, Olympia Fields, IL USA
[4] Univ Michigan Hlth, Wyoming, MI USA
关键词
Cystic lung disease; Smoking; Marijuana; Interstitial lung disease; Tobacco use; Langerhans cells; Smoking cessation; GRANULOMATOSIS;
D O I
10.1186/s12890-025-03513-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundPulmonary Langerhans Cell Histiocytosis (PLCH) is a rare interstitial lung disease primarily affecting young to middle-aged smokers. While traditionally linked to tobacco use, there is growing evidence that cannabis use may contribute to PLCH.MethodsWe present a case of a 52-year-old male with PLCH associated with heavy cannabis use. Diagnostic evaluations included CT scan of the chest and histopathological examination of a lung biopsy. In addition, a comprehensive review of the literature was conducted to identify and analyze similar cases of PLCH linked to cannabis use. Databases searched included PubMed and Google Scholar, following PRISMA guidelines.ResultsThe patient presented with dyspnea, cough and unintentional weight loss. The patient had a 20-year history of smoking approximately ten cannabis blunts per day. Despite normal initial chest X-ray findings, a CT scan of his chest revealed upper lobe predominant cystic changes and emphysema. Histopathology from a transbronchial biopsy confirmed the presence of Langerhans cells, consistent with PLCH. Literature review identified five additional case reports of PLCH associated with cannabis use, involving patients aged 16 to 59 years, with a mean age of 35.8 years. Common clinical presentations included cough, dyspnea, and chest pain, with radiographic findings of nodules and cysts. Treatment was primarily targeted towards smoking cessation, which led to clinical improvement in all cases.ConclusionsThis case underscores the potential association between heavy cannabis use and the development of PLCH. With the increasing prevalence of cannabis consumption, it is essential to recognize cannabis as a possible risk factor for PLCH. Further research is needed to understand the pathophysiological mechanisms underlying cannabis-related PLCH. As cannabis use becomes more prevalent with changing legislation, understanding its impact on lung health and potential role in diseases like PLCH is increasingly important.
引用
收藏
页数:9
相关论文
共 28 条
[1]   Langerhans cell histiocytosis: progress and controversies [J].
Abla, Oussama ;
Rollins, Barrett ;
Ladisch, Stephan .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (05) :559-562
[2]   Pulmonary Langerhan's cell histocystosis presenting with bilateral simultaneous pneumothoraces - Case report [J].
Buckley, Sophie ;
O'Reilly, Emily ;
Doyle, Deirdre ;
Murphy, Desmond .
RESPIRATORY MEDICINE CASE REPORTS, 2024, 48
[3]   PULMONARY LANGERHANS CELL HISTIOCYTOSIS IN A YOUNG MARIJUANA-SMOKING FEMALE WITH RECURRENT PNEUMOTHORACES [J].
Cassada, Ronald ;
Joseph, Carmel ;
Adams, Stephen .
CHEST, 2023, 164 (04) :3261A-3262A
[4]   HISTIOCYTOSIS-X IN THE LUNG [J].
COLBY, TV ;
LOMBARD, C .
HUMAN PATHOLOGY, 1983, 14 (10) :847-856
[5]   International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults [J].
Goyal, Gaurav ;
Tazi, Abdellatif ;
Go, Ronald S. ;
Rech, Karen L. ;
Picarsic, Jennifer L. ;
Vassallo, Robert ;
Young, Jason R. ;
Cox, Christian W. ;
Van Laar, Jan ;
Hermiston, Michelle L. ;
Cao, Xin-Xin ;
Makras, Polyzois ;
Kaltsas, Gregory ;
Haroche, Julien ;
Collin, Matthew ;
McClain, Kenneth L. ;
Diamond, Eli L. ;
Girschikofsky, Michael .
BLOOD, 2022, 139 (17) :2601-2621
[6]   Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis [J].
Kambouchner, M ;
Basset, FO ;
Marchal, L ;
Uhl, JF ;
Hance, AJ ;
Soler, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (11) :1483-1490
[7]   Langerhans cell (eosinophilic) granulomatosis - A clinicopathologic study encompassing 50 years [J].
Lieberman, PH ;
Jones, CR ;
Steinman, RM ;
Erlandson, RA ;
Smith, J ;
Gee, T ;
Huvos, A ;
GarinChesa, P ;
Filippa, DA ;
Urmacher, C ;
Gangi, MD ;
Sperber, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (05) :519-552
[8]   Response to Trametinib of a Pulmonary Langerhans Cell Histiocytosis Harboring a MAP2K1 Deletion [J].
Lorillon, Gwenael ;
Jouenne, Fanelie ;
Baroudjian, Barouyr ;
de Margerie-Mellon, Constance ;
Vercellino, Laetitia ;
Meignin, Veronique ;
Lebbe, Celeste ;
Vassallo, Robert ;
Mourah, Samia ;
Tazi, Abdellatif .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 198 (05) :675-678
[9]   How I manage pulmonary Langerhans cell histiocytosis [J].
Lorillon, Gwenael ;
Tazi, Abdellatif .
EUROPEAN RESPIRATORY REVIEW, 2017, 26 (145)
[10]   HOLE-D UP [J].
Mais, Lauren ;
Aquart-Stewart, Althea M. M. .
CHEST, 2022, 162 (04) :1768A-1768A